Experiments to vaccinate marmoset monkeys against malignant lymphoma.
Humoral antibodies can be induced in cotton topped (CT) marmosets with killed Herpesvirus saimiri (HVS) vaccines. The serum antibodies delayed, but did not prevent, malignant lymphoma in actively and passively immunized monkeys after inoculation with 10(3.8)TCID50 of cell-free HVS. Experiments are in progress to determine whether the vaccines are able to protect against smaller challenge dosages of HVS. The immunized monkeys were not resistant against transplantation of tumor cells. Infection with Epstein-Barr virus (EBV) and Marek's disease virus (MDV) did not protect against the tumors caused by superinfection with HVS. Attenuation of HVS was not achieved by passaging the HVS genome through different monkey species.
D000818:Animals; D000936:Antigen-Antibody Complex; D002143:Callitrichinae; D000882:Haplorhini; D006564:Herpesviridae / Q000276:immunology*; D008381:Herpesvirus 2, Gallid / Q000276:immunology; D006567:Herpesvirus 2, Saimiriine / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000276:immunology; D007110:Immunity, Active; D007112:Immunity, Maternally-Acquired; D008214:Lymphocytes / Q000382:microbiology; D008223:Lymphoma / Q000517:prevention & control*; D009368:Neoplasm Transplantation; D014184:Transplantation, Homologous; D014412:Tumor Virus Infections / Q000276:immunology; D014611:Vaccination; D014765:Viral Vaccines
D000936:Antigen-Antibody Complex; D014765:Viral Vaccines